REVIEW
Published on 26 Nov 2025
Celecoxib in oncology: targeting the COX-2/PGE2 axis to reprogram the tumor immune microenvironment and enhance multimodal therapy
doi 10.3389/fphar.2025.1691392
- 651 views
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Volume II: Tumour microenvironment in cancer research and drug discovery
Volume II: Tumour microenvironment in cancer research and drug discovery
2,952
Total downloads
12k
Total views and downloads
Articles
REVIEW
Published on 16 Sep 2025
IDO and TDO inhibitors in cancer immunotherapy: mechanisms, clinical development, and future directions
doi 10.3389/fphar.2025.1632446
- 2,597 views
- 1 citation
REVIEW
Published on 11 Aug 2025
Nanoengineered-based delivery systems to modulate CD4+ T cell responses in cancer: emerging paradigms in cancer immunotherapy
doi 10.3389/fphar.2025.1643791
- 2,083 views
REVIEW
Published on 11 Jun 2025
Tiragolumab and TIGIT: pioneering the next era of cancer immunotherapy
doi 10.3389/fphar.2025.1568664
- 3,595 views
- 6 citations
Published in
Frontiers in Pharmacology
Pharmacology of Anti-Cancer Drugs
Other participating journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore